686718-85-4

Basic information

• Product Name: Silane, (1,1-dimethylethyl)diphenyl[[(2R,4S,6E,8R)-2,4,6,8-tetramethyl-6-decen yl]oxy]-
• CAS NO: 686718-85-4
• Molecular Formula: C30H46OSi
• Molecular Weight: 450.78
• Mol File: 686718-85-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Silane, (1,1-dimethylethyl)diphenyl[[(2R,4S,6E,8R)-2,4,6,8-tetramethyl-6-decen yl]oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, (1,1-dimethylethyl)diphenyl[[(2R,4S,6E,8R)-2,4,6,8-tetramethyl-6-decen yl]oxy]-(686718-85-4)
• EPA Substance Registry System: Silane, (1,1-dimethylethyl)diphenyl[[(2R,4S,6E,8R)-2,4,6,8-tetramethyl-6-decen yl]oxy]-(686718-85-4)

Safety Data

• Hazardous Substances Data: 686718-85-4(Hazardous Substances Data)

Upstream product

• 686718-81-0 (R,E)-2-iodo-4-methyl-2-hexene 
• 686718-83-2 (2R,4S)-1-(tert-butyldiphenylsiloxy)-5-iodo-2,4-dimethylpentane 
• 917-54-4 methyllithium 
• 273738-38-8 Toluene-4-sulfonic acid (E)-(2S,6S,8R)-9-(tert-butyl-diphenyl-silanyloxy)-2,4,6,8-tetramethyl-non-3-enyl ester 
• 273738-52-6 (E)-(2S,6S,8R)-9-(tert-butyldiphenylsiloxy)-2,4,6,8-tetramethyl-3-nonen-1-ol 
• 246219-82-9 (S)-(((4,4-dibromo-2-methylbut-3-en-1-yl)oxy)methyl)benzene 
• 778640-45-2 (4S)-5-(benzyloxy)-4-methylpent-2-yne 
• 778640-54-3 (2S,3E,6S,8R)-1-(benzyloxy)-9-(tert-butyldiphenylsiloxy)-2,4,6,8-tetramethylnon-3-ene 
• 129032-45-7 (2R,4S)-2,4-dimethyl-1-<(tert-butyldiphenylsilyl)oxy>hex-5-ene 
• 778640-59-8 Methanesulfonic acid (2S,4R)-5-(tert-butyl-diphenyl-silanyloxy)-2,4-dimethyl-pentyl ester 
• 616-16-0 (R)-2-Methyl-1-butanol 
• 137-32-6 (+/-)-2-methyl-1-butanol 
• 2121-69-9 (2R,4S)-2,4-dimethylpentane-1,5-diol 
• 90270-02-3 (2R,4S)-1-hydroxy-2,4-dimethylpentyl acetate 

Relevant articles and documents

An improved synthesis of the scyphostatin side-chain

A formal synthesis of the lipophilic side-chain of scyphostatin has been achieved using a convergent synthesis, in 16% yield over six steps. This synthesis involves enzymatic desymmetrisation of a meso-diol, resolution of 2-methylbutan-1-ol, stereoselective hydrozirconation of a volatile acetylene and a Negishi-style cross coupling.

Total synthesis of (+)-scyphostatin, a potent and specific inhibitor of neutral sphingomyelinase

The five crucial steps in the first total synthesis of (+)-scyphostatin from D-arabinose involve (see picture): a) stereoselective aldol coupling to form a quaternary stereocenter, b) ring-closing metathesis (RCM) to construct the cyclohexene ring, c) Neg